1. Signaling Pathways
  2. GPCR/G Protein
  3. GPCR19

GPCR19 (G蛋白偶联受体19)

GPCR19 (TGR5, GPBAR1) is a plasma membrane-bound, G protein-coupled receptor that has bile acids as its ligand. GPCR19 is a regulator of energy homeostasis, bile acid homeostasis as well as glucose metabolism. GPCR19 transduces extracellular signals through heterotrimeric G proteins.

GPCR19 can be activated by bile acids and then it induces cAMP production. As a membrane receptor, GPCR19 can be internalized into the cytoplasm in response to its ligands. GPCR19 plays important roles in cell signaling pathways such as nuclear factor κB (NF-κB), AKT, and extracellular signal-regulated kinases (ERK). Its agonists may be potential drugs for the treatment of metabolic, inflammation, and digestive disorders. In addition, GPCR19 stimulates glucagon-like peptide 1 (GLP-1) secretion. It also has become an attractive therapeutic target for the prevention and/or the treatment of obesity and its highly associated Type II diabetes and metabolic syndrome.

GPCR19 相关产品 (28):

目录号 产品名 作用方式 纯度
  • HY-15677
    INT-777 Agonist ≥98.0%
    INT-777是有效的 TGR5 激动剂,EC50 为 0.82 μM。
  • HY-N0593
    Deoxycholic acid

    去氧胆酸

    Activator ≥98.0%
    Deoxycholic acid 激活 G 蛋白偶联胆汁酸受体TGR5
  • HY-13771
    Ursodeoxycholic acid

    熊去氧胆酸

    Agonist ≥98.0%
    Ursodeoxycholic acid (Ursodeoxycholate) 是由肠道细菌转化 (cheno)脱氧胆酸而产生的一种次级胆汁酸,是肠道屏障完整性的关键调节因子,对脂质代谢至关重要。Ursodeoxycholic acid 作为信号分子,通过与胆汁酸激活的受体相互作用发挥作用,包括G蛋白偶联的胆汁酸受体5 (TGR5GPCR19) 和法尼酯X受体 (FXR)。Ursodeoxycholic acid 可用于多种肝脏和胃肠道疾病的研究。具有口服活性。
  • HY-111534
    SBI-115 Antagonist 99.57%
    SBI-115 是一种 TGR5 (GPCR19) 拮抗剂。SBI-115 通过抑制 TGR5 降低多囊性肝病的肝囊肿形成。
  • HY-B0575
    Triamterene

    氨苯蝶啶

    Inhibitor 99.98%
    Triamterene是压敏型上皮钠离子通道(ENaC)阻断剂,有利尿作用。
  • HY-145234
    GPBAR1-IN-3 Agonist
    GPBAR1-IN-3 (Compound 14) 是一种选择性 GPBAR1 激动剂 (EC50=0.17 μM) 和 CysLT1R 拮抗剂。
  • HY-N0593S3
    Deoxycholic acid-13C Activator
    Deoxycholic acid-13C (Cholanoic acid-13C) 是一种 13C 标记的 Deoxycholic acid。Deoxycholic acid 激活 G 蛋白偶联胆汁酸受体TGR5
  • HY-N0593S2
    Deoxycholic acid-d6

    去氧胆酸 d6

    Activator
    Deoxycholic acid-d6 (Cholanoic Acid-d6) 是 Deoxycholic acid 的氘代物。Deoxycholic acid 激活 G 蛋白偶联胆汁酸受体TGR5
  • HY-14229
    TGR5 Receptor Agonist Agonist 99.86%
    TGR5 Receptor Agonist (CCDC) 是 TGR5(GPCR19) 激动剂。
  • HY-N0169
    Hyodeoxycholic acid

    猪去氧胆酸

    Agonist ≥99.0%
    Hyodeoxycholic acid 是有肠道菌群在小肠中形成的次级胆汁酸,为 TGR5 (GPCR19) 的激动剂,在 CHO 细胞中,EC50 值为 31.6 µM。
  • HY-N0593A
    Deoxycholic acid sodium salt

    脱氧胆酸钠

    Activator ≥98.0%
    Deoxycholic acid sodium salt 激活 G 蛋白偶联胆汁酸受体TGR5
  • HY-12434
    INT-767 Agonist ≥98.0%
    INT-767 是法尼醇 X 受体 (FXR)/TGR5双激动剂,EC50 值分别为 30 和 630 nM。
  • HY-101274
    BAR501 Agonist ≥98.0%
    BAR501是高效选择性的GPBAR1激动剂,EC50值为1 μM。
  • HY-102016
    SB756050 Agonist 99.32%
    SB756050 是选择性的 TGR5 激动剂。SB756050有潜力用于二型糖尿病的研究。
  • HY-110173
    TC-G 1005 Agonist 99.91%
    TC-G 1005 是一种有效,选择性和口服活性的 TGR5 激动剂,激活 hTGR5 和 mTGR5 的 EC50 值分别为 0.72 和 6.2 nM。TC-G 1005 可降低小鼠体内葡萄糖水平。
  • HY-101273
    BAR502 Agonist ≥98.0%
    BAR502是FXRGPBAR1的双重激动剂,IC50值分别为2 μM 和0.4 μM。
  • HY-15677A
    INT-777 R-enantiomer Agonist
    INT-777 R-enantiomer 是 INT-77 的 R 型异构体,对 TGR5 的 EC50 值为 4.79 μM,活性比 INT-777 低。
  • HY-P2278
    PEN (human) Agonist
    PEN (human) 是由 ProSAAS 原蛋白衍生而来的最丰富的下丘脑神经肽之一,是 GPR83 的内源性配体。
  • HY-N0593S
    Deoxycholic acid-d4

    去氧胆酸 d4

    Activator
    Deoxycholic acid-d4 是 Deoxycholic acid 的氘代物。Deoxycholic acid 激活 G 蛋白偶联胆汁酸受体TGR5
  • HY-P2277
    PEN (rat) Agonist
    PEN (rat) 是由 ProSAAS 原蛋白衍生而来的最丰富的下丘脑神经肽之一,是 GPR83 的内源性配体。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.